Home | DAIC

Results show drug is effective and safe, leaves open question of optimal dosing

News | Cardiovascular Clinical Studies

Study Finds Olezarsen Cuts Triglyceride Levels by About Half

April 7, 2024 — An estimated 1 in 5 U.S. adults—and more than 2 in 5 adults aged 60 years and older—have elevated ...

April 07, 2024

90% of high-risk patients on lerodalcibep achieved guideline-recommended cholesterol targets

News | Cardiovascular Clinical Studies

Novel PCSK9 Inhibitor Cut LDL Cholesterol Levels by More Than Half

April 7, 2024 — Among patients at high or very high risk for a heart attack or stroke, the addition of the ...

April 07, 2024

Novel drug shows promise for treating severe hypertriglyceridemia in patients at high risk for pancreatitis

News | Cardiovascular Clinical Studies

Plozasiran Reduces Triglyceride Levels by 74% at 24 Weeks

April 7, 2024 — In patients with severely elevated triglyceride levels at risk for developing acute pancreatitis, the ...

April 07, 2024

Sponsored Content

Feature | Cardiac Imaging

Providing Clarity into CAD

Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...

March 13, 2026

$Study shows no benefit for heart failure overall but suggests different effects in those with preserved versus reduced ejection fraction$

News | Cardiovascular Clinical Studies

RELIEVE-HF Trial Outcomes Reported at ACC.24 Find Impact of Interatrial Shunt May Vary by Heart Failure Type

April 6, 2024 — Patients with heart failure who had a small shunt inserted between the heart’s left and right atria did ...

April 06, 2024

While composite of death and heart failure hospitalizations was not significantly reduced, empagliflozin may help reduce heart failure risks after a heart attack

News | Cardiovascular Clinical Studies

EMPACT-MI Trial Outcomes Reported at ACC.24: SGLT-2 Inhibitors Show Mixed Results After Heart Attack

April 6, 2024 — Use of the sodium glucose cotransporter-2 (SGLT-2) inhibitor empagliflozin following a heart attack did ...

April 06, 2024

Exploratory analysis finds beneficial effect on patient outcomes at one year, according to a study presented at ACC.24.

News | Cardiovascular Clinical Studies

Research Presented at ACC 2024 Found No Reduction in 90-Day Deaths, Heart Attacks With Human Apo/A1

April 6, 2024 — The first trial of a novel strategy for removing cholesterol from patients’ arteries did not reduce the ...

April 06, 2024

Sponsored Content

Feature | Nuclear Imaging

Cardiac PET/CT — A New Standard for Cardiac Imaging

Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...

November 12, 2025

The Minneapolis Heart Institute Foundation (MHIF) is presenting data on trends in ST-elevation myocardial infarction (STEMI) at the American College of Cardiology’s Annual Scientific Session (ACC.24). An analysis of nearly 8,000 STEMI patients over 20 years found the majority of STEMI occur in individuals without prior cardiovascular disease.

News | ACC

Research Data from Minneapolis Heart Institute Foundation at ACC 2024 Reveal Trends in Cardiovascular Risk Factors and Preventive Medication Use Prior to Heart Attacks

April 6, 2024 — The Minneapolis Heart Institute Foundation (MHIF) is presenting leading research focused on trends in ST ...

April 06, 2024

Smidt Heart Institute experts will be available for media interviews throughout ACC.24.

News | Artificial Intelligence

ACC.24: Smidt Heart Institute Experts to Share Research Findings, Clinical Knowledge

April 6, 2024 — Experts from the Smidt Heart Institute at Cedars-Sinai will share new research and participate in more ...

April 06, 2024

Registration is open for a leading conference on structural heart disease announced by the Cardiovascular Research Foundation, CRF.

News | Cardiovascular Business

Cardiovascular Research Foundation, CRF, Introduces New York Valves: The Structural Heart Summit

April 5, 2024 — The Cardiovascular Research Foundation (CRF) has announced New York Valves: The Structural Heart Summit ...

April 05, 2024

Sponsored Content

Feature

Intuitive Imaging Workflow System Offers Improved Efficiency, Flexibility

SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...

June 17, 2025

Cardiawave SA will present the 30-day follow-up results for 60 patients enrolled in its European pivotal study to the 73rd annual conference of the American College of Cardiology in Atlanta, Georgia

News | Cardiovascular Ultrasound

Cardiawave is Presenting the 30-day Follow-up Results from its “Valvosoft Pivotal Study” on the Teatment of Severe Symptomatic Aortic Valve Stenosis at ACC24

April 5, 2024 — Cardiawave SA, a French medtech company that has developed an innovative Non-Invasive focused Ultrasound ...

April 05, 2024

The acquisition enhances Johnson and Johnson’s ability to transform the treatment landscape for cardiovascular disease and continue to improve patient outcomes

News | Cardiovascular Business

Johnson and Johnson to Acquire Shockwave Medical

April 5, 2024 — Johnson & Johnson and Shockwave Medical, Inc. today announced that they have entered into a definitive ...

April 05, 2024

Viz.ai will be announced new clinical data supporting advancements in cardiology care during the American College of Cardiology Scientific Sessions, ACC.24

News | Artificial Intelligence

Real-world Evidence at the American College of Cardiology Scientific Session ACC.24 to Demonstrate Positive Impact of Viz.ai on Suspected Disease Detection and Patient Triage for Improved Care

April 4, 2024 — Viz.ai, a leader in AI-powered disease detection and intelligent care coordination, announced new ...

April 04, 2024

Sponsored Content

ASCEND provides the tools that not only address the unique needs of each cardiovascular subspecialty and to care for patients from infancy into their golden years, they also innovates next-generation solutions and services that empower the provider community to truly transform their cardiovascular services

Feature | Information Technology

SPONSORED CONTENT: Unveiling the Future of Cardiovascular Workflow

Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...

March 21, 2024

Virtual Reality Simulation Company Collaborates with American College of Cardiology to Help Cardiovascular Clinicians Immersively Practice Clinical Procedures

News | Left Atrial Appendage (LAA) Occluders

Osso VR Expands Cardiology Training through ACC Collaboration

April 4, 2024 — Osso VR, a leader in immersive procedural training, announces the release of a co-developed curriculum ...

April 04, 2024

Early coronary disease and impaired heart function, with increased coronary vessel wall thickness, in asymptomatic, middle-aged individuals living with HIV has been reported in a new study published today in Radiology: Cardiothoracic Imaging, a journal of the Radiological Society of North America (RSNA).

News | Population Health

New Study Finds Early Coronary Disease, Impaired Heart Function in Asymptomatic People with HIV

April 4, 2024 — A new study found increased coronary vessel wall thickness that was significantly associated with ...

April 04, 2024

The FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries or death.

News | Balloon Catheter

FDA Announces Medos International Sàrl Recall of Cerenovus CEREBASE DA Guide Sheath due to Cracking of the Distal Catheter Shaft

April 4, 2024 — The U.S. Food and Drug Administration (FDA) announced that Medos International Sàrl is recalling ...

April 04, 2024